Phreesia Inc(PHR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 60.21 | EPS (ttm) | 0.17 | Insider Own | 8.31% | Shs Outstand | 62.0M | Perf Week | -14.18% |
| Market Cap | 0.63B | Forward P/E | 15.8 | EPS next Y | 116.65% | Insider Trans | 120.74% | Shs Float | 56.9M | Perf Month | -17.11% |
| Enterprise Value | 0.63B | PEG | 0.1 | EPS next Q | 0.12 | Inst Own | 95.53% | Short Float | 4.75% | Perf Quarter | 11.27% |
| Income | 0.01B | P/S | 1.24 | EPS this Y | 642.81% | Inst Trans | -0.51% | Short Ratio | 3.05 | Perf Half Y | -10.32% |
| Sales | 0.51B | P/B | 1.7 | EPS next 5Y | 164.07% | ROA | 1.98% | Short Interest | 2.71M | Perf YTD | -39.89% |
| Book/sh | 5.99 | P/C | 8.65 | EPS past 3/5Y | - | ROE | 3.12% | 52W High | -62.33% ($27.00) | Perf Year | -59.87% |
| Cash/sh | 1.18 | P/FCF | 8.38 | Sales past 3/5Y | 19.6% 26.45% | ROIC | 2.41% | 52W Low | 30.89% ($7.77) | Perf 3Y | -53.56% |
| Dividend Est. | - | EV/EBITDA | 9.94 | EPS Y/Y TTM | 141.6% | Gross Margin | 60.12% | Volatility(W/M) | 4.2% 4.05% | Perf 5Y | -85.53% |
| Dividend TTM | - | EV/Sales | 1.23 | Sales Y/Y TTM | 12.93% | Oper. Margin | 5.01% | ATR (14) | 0.5 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.76 | EPS Q/Q | 189.62% | Profit Margin | 2.06% | RSI (14) | 34.59 | Recom | 1.95 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.76 | Sales Q/Q | 10.41% | SMA20 | -12.13% ($11.57) | Beta | 0.85 | Target Price | $13.94 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/9/2 | SMA50 | -9.51% ($11.24) | Rel Volume | 0.63 | Prev Close | $10.34 |
| Employees | 1789 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | -64.75% 0.31% | SMA200 | -16.36% ($12.16) | Avg Volume(3M) | 0.89M | Price | $10.17 |
| IPO | 2019/7/18 | Option/Short | Yes/Yes | Trades | 7166 | Volume | 556,582 | Change | -1.64% |
Company
PHR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 Phreesia (ticker: PHR) is a U.S. healthcare information technology platform company that digitizes patient intake, billing, and engagement for medical providers. It automates administrative workflows such as appointment scheduling, pre-visit questionnaires, insurance verification, and patient payments, helping hospitals and clinics improve operational efficiency. By combining subscription fees, payment transaction fees, and data- and analytics-driven value-added services, the company has continued to deliver rapid revenue growth.
Over the past 1 year, on the lower side
62% below its 1-year high.
PHR makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +642.8% this year.
Tap to view numbers
The price looks about right
Trading at 60.2 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -53.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 95.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HEAL 0.01%
XITK 0.01%
SFLO 0.00%
AFSM 0.00%
ISMD 0.00%It ranks #4 in the industry
Based on market cap of $631M.
PHR $631M PER 60.2
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is PHR?
PHR belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of PHR?
The market cap of PHR is approximately $631M, ranking 3,025 within its sector.
What is the P/E ratio of PHR?
PHR has a P/E ratio of approximately 60.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PHR?
PHR has recorded a 52-week high of $27.00 and a low of $7.77.
